New £750 million UK cancer strategy to fund drugs and stimulate molecular diagnostics
This article was originally published in Scrip
Executive Summary
The department of health in the UK has announced new plans, to be allocated £750 million over four years, for improving outcomes in cancer. They largely hinge on earlier and better diagnosis, improved screening, placing greater emphasis on prevention, and improving access to high quality care, support and treatment. The latter places a high emphasis on drugs, although there are few surprises about what the government has in mind.